Kensho is S&P Global’s hub for AI innovation and transformation. With expertise in machine learning, natural language processing, and data discovery, we develop and deploy novel solutions to innovate and drive progress at S&P Global and
Alnylam Pharmaceuticals is seeking an imaginative physician drug developer in Clinical Research - Cardiovascular & Metabolism (CVM) therapeutic area, also with the flexibility and confidence to work in therapeutic areas that may be beyond their expertise or
Amylyx has an audacious mission to usher in a new era for treating diseases with high unmet needs. Where others see challenges, we see opportunities that we pursue with urgency, rigorous science, and unwavering commitment to the